In addition to the deregulation of aberrant signaling pathways for tumor growth and survival, MSCs are notable for their expression of CD20, CD133, CD166, CD271, ABCB5, Nestin, and CD105 surface markers [4,5,8]. The gene discussed is ABCB5; the disease is neoplasm.